Michael J. Currens
Frederick National Laboratory for Cancer Research(US)
Publications by Year
Research Areas
HIV Research and Treatment, HIV/AIDS drug development and treatment, Natural Compound Pharmacology Studies, Carbohydrate Chemistry and Synthesis, Natural product bioactivities and synthesis
Most-Cited Works
- Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.(1988)
- → Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development(1997)612 cited
- → HIV inhibitory natural products. Part 7. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum(1992)546 cited
- → Michellamine B, a novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing by at least two distinct mechanisms(1995)126 cited
- → Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase(1993)124 cited
- → Application of High-Throughput, Molecular-Targeted Screening to Anticancer Drug Discovery(2002)92 cited
- → Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors(1993)88 cited
- → Antiviral activity and mechanism of action of calanolide A against the human immunodeficiency virus type-1.(1996)72 cited
- → Analysis of the Interaction between the HIV-Inactivating Protein Cyanovirin-N and Soluble Forms of the Envelope Glycoproteins gp120 and gp41(2000)71 cited
- → Comparative anti-HIV evaluation of diverse HIV-1-specific reverse transcriptase inhibitor-resistant virus isolates demonstrates the existence of distinct phenotypic subgroups(1995)63 cited